Cite
SOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression.
MLA
Hosseini-khah, Zahra, et al. “SOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression.” Current Oncology, vol. 28, no. 4, Aug. 2021, pp. 3015–29. EBSCOhost, https://doi.org/10.3390/curroncol28040264.
APA
Hosseini-khah, Z., Babaei, M. R., Tehrani, M., Cucchiarini, M., Madry, H., Ajami, A., Rakhshani, N., Rafiei, A., & Nikbin, B. (2021). SOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression. Current Oncology, 28(4), 3015–3029. https://doi.org/10.3390/curroncol28040264
Chicago
Hosseini-khah, Zahra, Mohammad Reza Babaei, Mohsen Tehrani, Magali Cucchiarini, Henning Madry, Abolghasem Ajami, Nasser Rakhshani, Alireza Rafiei, and Behrooz Nikbin. 2021. “SOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression.” Current Oncology 28 (4): 3015–29. doi:10.3390/curroncol28040264.